by Team Small News | Jun 19, 2025 | Glenmark, Pharma
The U.S. Food and Drug Administration (FDA) recently conducted a Good Manufacturing Practice (GMP) inspection of Glenmark Pharmaceuticals’ manufacturing facility in Monroe, North Carolina. The inspection, which took place from June 9-17, resulted in the FDA... by Team Small News | Jun 18, 2025 | Glenmark, Pharma
Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals Ltd, reflects on the company’s over two-decade journey, highlighting the challenges of transitioning from a generic-focused business to a more innovative space. Saldanha notes that this... by Team Small News | Jun 11, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals, a renowned drug company, has announced its plan to launch a cancer treatment drug called zanubrutinib, also known as Brukinsa, in India. The drug has been approved by the Drugs Controller General of India (DCGI) and will be used to treat five... by Team Small News | Jun 6, 2025 | Glenmark, Pharma
Glenmark, an Indian pharmaceutical company, recently reported its earnings for the 2025 financial year. While the company’s overall performance was affected by a weak second half in its India business, it is planning to revive growth in both its core markets:... by Team Small News | Jun 2, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals’ latest earnings report may appear impressive at first glance, but a closer examination reveals some underlying weaknesses. The company’s net profit increased by 15.6% year-over-year, reaching ₹2.16 billion, and revenue grew by... by Team Small News | May 24, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has announced its financial results for the fourth quarter and full year ended March 2025, highlighting a solid profit growth despite increasing interest costs. The company’s performance was driven by robust sales across its key markets...